Stockholders' Equity (Tables)
|
6 Months Ended |
Jun. 30, 2022 |
Equity [Abstract] |
|
Summary of Stock Options Activity |
The activity for stock options under the Company’s stock plans for the six months ended June 30, 2022 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
weighted- |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted- |
|
|
average |
|
|
Per share |
|
|
|
|
|
|
|
|
|
average |
|
|
contractual |
|
|
average |
|
|
|
|
|
|
Price per |
|
|
exercise |
|
|
terms |
|
|
intrinsic |
|
|
|
Options |
|
|
share |
|
|
price |
|
|
(in years) |
|
|
value |
|
Outstanding as of December 31, 2021 |
|
|
459,441 |
|
|
$1.17-$83.30 |
|
|
$ |
42.18 |
|
|
|
1.36 |
|
|
$ |
4.31 |
|
Exercised |
|
|
(8,649 |
) |
|
1.17-8.37 |
|
|
|
4.08 |
|
|
|
|
|
|
|
Forfeited |
|
|
(7,500 |
) |
|
38.54-44.19 |
|
|
|
42.31 |
|
|
|
|
|
|
|
Expired |
|
|
(54,755 |
) |
|
|
38.54 |
|
|
|
38.54 |
|
|
|
|
|
|
|
Outstanding as of June 30, 2022 |
|
|
388,537 |
|
|
1.17-83.30 |
|
|
|
43.54 |
|
|
|
0.88 |
|
|
|
2.84 |
|
Vested and exercisable as of June 30, 2022 |
|
|
388,537 |
|
|
1.17-83.30 |
|
|
|
43.54 |
|
|
|
0.88 |
|
|
|
2.84 |
|
Vested and expected to vest as of June 30, 2022 |
|
|
388,537 |
|
|
$1.17-$83.30 |
|
|
$ |
43.54 |
|
|
|
0.88 |
|
|
$ |
2.84 |
|
|
Summary of Restricted Stock Activity |
Stock Awards activity for the six months ended June 30, 2022 is summarized below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted- |
|
|
|
|
|
|
|
|
|
|
|
|
average |
|
|
|
|
|
|
|
|
|
|
|
|
grant |
|
|
|
|
|
|
Performance |
|
|
|
|
|
date fair |
|
|
|
|
|
|
and |
|
|
|
|
|
value |
|
Restricted stock units |
|
Time-based |
|
|
time-based |
|
|
Total |
|
|
per share |
|
Unvested restricted stock units as of December 31, 2021 |
|
|
289,166 |
|
|
|
99,112 |
|
|
|
388,278 |
|
|
$ |
54.81 |
|
Granted |
|
|
640,667 |
|
|
|
164,722 |
|
|
|
805,389 |
|
|
|
30.18 |
|
Vested |
|
|
(96,295 |
) |
|
|
(37,677 |
) |
|
|
(133,972 |
) |
|
|
55.72 |
|
Forfeited/canceled |
|
|
(55,384 |
) |
|
|
(27,716 |
) |
|
|
(83,100 |
) |
|
|
47.66 |
|
Unvested restricted stock units as of June 30, 2022 (1) |
|
|
778,154 |
|
|
|
198,441 |
|
|
|
976,595 |
|
|
$ |
34.97 |
|
Unvested and expected to vest restricted stock units outstanding as of June 30, 2022 |
|
|
|
|
|
|
|
|
816,827 |
|
|
$ |
34.63 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted- |
|
|
|
|
|
|
|
|
|
|
|
|
average |
|
|
|
|
|
|
|
|
|
|
|
|
grant |
|
|
|
|
|
|
Performance |
|
|
|
|
|
date fair |
|
|
|
|
|
|
and |
|
|
|
|
|
value |
|
Restricted stock awards |
|
Time-based |
|
|
time-based |
|
|
Total |
|
|
per share |
|
Unvested restricted stock awards outstanding as of December 31, 2021 |
|
|
10,416 |
|
|
|
5,629 |
|
|
|
16,045 |
|
|
$ |
87.12 |
|
Vested |
|
|
(3,327 |
) |
|
|
(5,629 |
) |
|
|
(8,956 |
) |
|
|
99.53 |
|
Forfeited/canceled |
|
|
(5,011 |
) |
|
|
— |
|
|
|
(5,011 |
) |
|
|
73.45 |
|
Unvested restricted stock awards outstanding as of June 30, 2022 (1) |
|
|
2,078 |
|
|
|
— |
|
|
|
2,078 |
|
|
$ |
84.50 |
|
Unvested and expected to vest restricted stock awards outstanding as of June 30, 2022 |
|
|
|
|
|
|
|
|
1,984 |
|
|
$ |
85.06 |
|
(1) Outstanding restricted stock units and restricted stock awards are based on the maximum payout of the targeted number of shares.
|
Summary of Stock-based Compensation Expense |
Stock-based compensation
Stock-based compensation expense recognized for the three and six months ended June 30, 2022 and 2021, was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Six months ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
Stock-based compensation expense by type of award: |
|
|
|
|
|
|
|
|
|
|
|
|
Restricted stock units and restricted stock awards |
|
|
2,891 |
|
|
$ |
3,053 |
|
|
|
5,359 |
|
|
|
5,383 |
|
Employee stock purchase plan |
|
|
129 |
|
|
|
186 |
|
|
|
326 |
|
|
|
372 |
|
Total stock-based compensation expense |
|
$ |
3,020 |
|
|
$ |
3,239 |
|
|
$ |
5,685 |
|
|
$ |
5,755 |
|
For the three and six months ended June 30, 2022 and 2021, respectively, stock-based compensation expense recognized under ASC 718, included in cost of revenue, research and development expense, sales and marketing expense, and general and administrative expense was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Six months ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
Cost of revenue |
|
$ |
303 |
|
|
$ |
319 |
|
|
$ |
536 |
|
|
$ |
557 |
|
Research and development |
|
|
412 |
|
|
|
382 |
|
|
|
796 |
|
|
|
680 |
|
Sales and marketing |
|
|
766 |
|
|
|
668 |
|
|
|
1,357 |
|
|
|
1,280 |
|
General and administrative |
|
|
1,539 |
|
|
|
1,870 |
|
|
|
2,996 |
|
|
|
3,238 |
|
Total stock-based compensation expense |
|
$ |
3,020 |
|
|
$ |
3,239 |
|
|
$ |
5,685 |
|
|
$ |
5,755 |
|
|